A Novel Protein Encoded by Exosomal CircATG4B Induces Oxaliplatin Resistance in Colorectal Cancer by Promoting Autophagy.
A Novel Protein Encoded by Exosomal CircATG4B Induces Oxaliplatin Resistance in Colorectal Cancer by Promoting Autophagy.
复制标题
外泌体 CircATG4B 编码的新型蛋白质通过促进自噬诱导结直肠癌奥沙利铂耐药
DOI:
10.1002/advs.202204513
复制
发表时间:
2022-12
期刊:
影响因子:
15.1
通讯作者:
Li, Yong
中科院分区:
文献类型:
--
作者:
Pan, Zihao;Zheng, Jun;Zhang, Jiebin;Lin, Jiatong;Lai, Jianguo;Lyu, Zejian;Feng, Huolun;Wang, Junjiang;Wu, Deqing;Li, Yong
Oxaliplatin is commonly used in chemotherapeutic regimens for colorectal cancer (CRC) after surgical resection. However, acquired chemoresistance seriously affects the curative effect in CRC patients, and the mechanism is still unclear. Here, a circular RNA, circATG4B is identified, which plays an important role in oxaliplatin resistance in CRC. circATG4B expression is found to be increased in exosomes secreted by oxaliplatin‐resistant CRC cells. In addition, the results suggest that circATG4B induces oxaliplatin resistance by promoting autophagy. Further in vivo and in vitro studies indicate that the effect of circATG4B is attributed to its potential to encode a novel protein, circATG4B‐222aa. Next, circATG4B‐222aa is found to function as a decoy to competitively interact with TMED10 and prevent TMED10 from binding to ATG4B, which leads to increased autophagy followed by induction of chemoresistance. Therefore, this study reveals that exosomal circATG4B participates in the decreased chemosensitivity of CRC cells, providing a new rationale for a potential therapeutic target for oxaliplatin resistance in CRC.
登录
查看更多内容
影响因子:
37.3
作者:
Pan, Zihao;Cai, Jianye;Zhang, Lei
通讯作者:
Zhang, Lei
影响因子:
16.6
作者:
Pengo N;Agrotis A;Prak K;Jones J;Ketteler R
通讯作者:
Ketteler R
影响因子:
37.3
作者:
Peng L;Sang H;Wei S;Li Y;Jin D;Zhu X;Li X;Dang Y;Zhang G
通讯作者:
Zhang G
影响因子:
21.3
作者:
Gao, Xinya;Xia, Xin;Zhang, Nu
通讯作者:
Zhang, Nu
影响因子:
4
作者:
Liu, Fen;Ai, Fei-Yan;Liu, Shao-Jun
通讯作者:
Liu, Shao-Jun